» Authors » E Kostopoulou

E Kostopoulou

Explore the profile of E Kostopoulou including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 36
Citations 179
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kostopoulou E, Kalavrizioti D, Davoulou P, Plotas P, Sinopidis X, Papachristou E, et al.
Eur Rev Med Pharmacol Sci . 2024 Nov; 28(21):4536-4545. PMID: 39560929
Objective: Type 1 diabetes mellitus (DM1) and obesity represent two chronic pediatric diseases characterized by increased risk for renal impairment and cardiovascular disease. The potential usefulness of neutrophil gelatinase-associated lipocalin...
2.
Gkentzi D, Plotas P, Terzi M, Bertzouanis A, Karantaglis N, Gidaris D, et al.
Eur Rev Med Pharmacol Sci . 2023 Sep; 27(16):7728-7737. PMID: 37667951
Objective: The impact of COVID-19 vaccination on parental and childhood stress levels has not been thoroughly investigated. Our aim was to explore the above relationship and identify factors that may...
3.
Panagopoulou K, Gkentzi D, Fouzas S, Mentis M, Kostopoulou E, Plotas P, et al.
Eur Rev Med Pharmacol Sci . 2023 Feb; 27(2):659-672. PMID: 36734738
Objective: This study aims to record the overall perception of healthcare professionals on child abuse and identify potential affecting factors in a nationwide scale in Greece as well as to...
4.
Kostopoulou E, Spilioti D, Pantzaris N, Spiliotis B
Eur Rev Med Pharmacol Sci . 2022 Apr; 26(7):2437-2442. PMID: 35442499
Objective: Prader-Willi syndrome (PWS) is a genomic imprinting disorder predominantly caused by the absence of paternally expressed imprinted genes at chromosome 15q11.2-q13. The PCSK1 gene is vital for the processing...
5.
Mourelatou R, Kostopoulou E, Rojas-Gil A, Sinopidis X, Kehagias I, Linos D, et al.
Eur Rev Med Pharmacol Sci . 2022 Apr; 26(6):2134-2142. PMID: 35363363
Objective: Obesity is characterized by hypertrophy and pathological expansion of adipocytes with impaired insulin signaling causing insulin resistance (IR) and metabolic dysfunction. We recently reported decreased expression of glucose transporter-4...
6.
Kostopoulou E, Avgeri A, Apostolou M, Tzifas S, Dimitriou G
Eur Rev Med Pharmacol Sci . 2022 Mar; 26(4):1108-1113. PMID: 35253165
Objective: Mutations in the ATP1A3 gene cause the classical disorders of rapid-onset dystonia-parkinsonism (RDP), alternating hemiplegia of childhood (AHC) and cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing...
7.
Kostopoulou E, Lagadinou M, Avgeri A, Varvarigou A
Eur Rev Med Pharmacol Sci . 2021 Dec; 25(22):7093-7096. PMID: 34859874
Objective: The co-occurrence of coeliac disease (CD) and type 1 diabetes mellitus (T1DM) is well described and is mainly explained by sharing of common pathogenic mechanisms, such as common high-risk...
8.
Tsekoura E, Kostopoulou E, Fouzas S, Souris E, Gkentzi D, Jelastopulu E, et al.
Eur Rev Med Pharmacol Sci . 2021 Oct; 25(19):6051-6056. PMID: 34661265
Objective: Eating disorders and obesity are serious, multifactorial diseases with increasing prevalence worldwide, often manifesting during childhood and adolescence. The aim of this study was to investigate the risk for...
9.
Kostopoulou E, Tikka M, Rojas Gil A, Partsalaki I, Spiliotis B
Eur Rev Med Pharmacol Sci . 2021 Oct; 25(19):5986-5992. PMID: 34661258
Objective: Type 2 diabetes mellitus (T2DM) and obesity are alarmingly increasing in children and adolescents. Hence, predictors for early metabolic abnormalities in childhood are urgently needed. We investigated glucose tolerance...
10.
Kostopoulou E, Eliopoulou M, Rojas Gil A, Chrysis D
Eur Rev Med Pharmacol Sci . 2021 Oct; 25(19):5928-5935. PMID: 34661251
Objective: A positive relationship between the recently emerged Corona Virus Disease-19 (COVID-19) and diabetes has been inferred, but not confirmed, in children. The aim of the present study was to...